Discovery of Biphenyl-Substituted Diarylpyrimidines as New Non-Nucleoside HIV-1 Reverse Transcripttase Inhibitors

Documenti analoghi

• Scaffold Hopping in Discovery of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: From CH(CN)-DABOs to CH(CN)-DAPYs
  di: Ting-Ting Li, et al.
  Pubblicazione: (2020-03-01)
• Discovery of Biphenyl-Substituted Diarylpyrimidines as New Non-Nucleoside HIV-1 Reverse Transcripttase Inhibitors
  di: Kaijun Jin, et al.
  Pubblicazione: (2017-10-01)
• Structure-based design of novel heterocycle-substituted ATDP analogs as non-nucleoside reverse transcriptase inhibitors with improved selectivity and solubility
  di: Li-Min Zhao, et al.
  Pubblicazione: (2023-12-01)
• Bioisosterism-driven design of orally active, safe, and broad-spectrum biphenyl-DAPY derivatives as highly potent HIV-1 non-nucleoside reverse transcriptase inhibitors
  di: Xiao-Mei Chen, et al.
  Pubblicazione: (2025-08-01)
• Identification of Boronate-Containing Diarylpyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
  di: Da Feng, et al.
  Pubblicazione: (2022-11-01)